Vanguard Group Inc Exagen Inc. Call Options Transaction History
Vanguard Group Inc
- $5.12 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding XGN
# of Institutions
38Shares Held
6.29MCall Options Held
2.5KPut Options Held
200-
Rtw Investments, LP New York, NY1.51MShares$3.79 Million0.05% of portfolio
-
Cowen And Company, LLC891KShares$2.24 Million0.04% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT762KShares$1.91 Million0.01% of portfolio
-
Silvercrest Asset Management Group LLC New York, NY545KShares$1.37 Million0.01% of portfolio
-
Morgan Stanley New York, NY482KShares$1.21 Million0.0% of portfolio
About EXAGEN INC.
- Ticker XGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 16,260,400
- Market Cap $40.8M
- Description
- Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...